Recently, FBXW7 has been shown to degrade ZFP36 to regulate sorafenib-induced ferroptosis, revealing that ferroptosis is a therapeutic target for liver fibrosis (Zhang et al., 2020). This evidence concerns the gene FBXW7 and Hepatic fibrosis.